GURU.Markets stock price, segment price, and overall market index valuation
The company's share price SeaStar Medical Holding
The shares of SeaStar Medical, a company developing devices for sepsis treatment, reflect its struggle for commercialization. Their price trajectory is volatile and depends on the results of clinical trials and FDA approvals.
Share prices of companies in the market segment - Therapeutic medical equipment
SeaStar Medical is a medical company that has developed a device for selective cytopheretic therapy, which helps reduce inflammation in critically ill patients. We've categorized it as "Therapeutic Medical Equipment." The graph below shows the dynamics in the critical care sector.
Broad Market Index - GURU.Markets
SeaStar Medical is a medical company that has developed a device for selective cytopheretic therapy, which helps reduce immune system hyperactivity in acute conditions. It is a component of the GURU.Markets index, and the chart below shows how its stock compares to the market.
Change in the price of a company, segment, and market as a whole per day
ICU - Daily change in the company's share price SeaStar Medical Holding
SeaStar Medical Holding Corp.'s daily price change reflects the high volatility of the medical equipment sector. The indicator demonstrates sensitivity to news about the use of its blood purification technology in acute kidney injury.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
SeaStar Medical Holding Corporation is a company in the medical device sector. This chart illustrates the high volatility of the MedTech industry. Comparing it to the dynamics of the ICU, which focuses on sepsis treatment, helps assess the extent to which its innovative products contribute to its volatility.
Daily change in the price of a broad market stock, index - GURU.Markets
SeaStar Medical develops devices to purify blood from inflammatory cytokines in critical conditions. This innovative medtech company's shares are responding to clinical successes and regulatory decisions, contributing to the overall volatility of the healthcare sector.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization SeaStar Medical Holding
SeaStar Medical Holding's annual performance reflects the development of its device for the treatment of acute kidney injury. Its 12-month market capitalization depends entirely on clinical trial data and FDA approval. The success of its selective cytopheretic device could offer a new way to combat sepsis and other critical conditions.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
SeaStar Medical is a medical device company developing blood purification devices for acute medical conditions. Its stock price is entirely dependent on clinical trial results and regulatory decisions. The chart reflects the high risks and potential for breakthroughs in this critically important area of medicine.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
SeaStar, with its blood purification technology, is a high-risk, high-potential story. Its stock price is entirely dependent on the results of its clinical trials. The chart isn't about economics, but rather whether investors believe its revolutionary approach will become the new standard in intensive care.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization SeaStar Medical Holding
SeaStar Medical develops critical care devices. Its monthly revenue is entirely dependent on clinical and regulatory developments. News about the trial results of its sepsis treatment device and its interactions with the FDA are the main drivers of its value.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
This chart reflects the dynamics of the biotech sector, particularly in the field of critical care. For SeaStar, a clinical-stage company, this is the backdrop. Its volatile movements demonstrate how investor expectations surrounding its sepsis treatment device are impacting its valuation.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
SeaStar Medical is developing a medical device for selective cytopheretic blood filtration to treat hyperactive inflammation. The company's success depends on regulatory approval. The overall market chart provides only background; SeaStar shares are driven by news of medical breakthroughs, and their volatility can be extreme, defying overall trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization SeaStar Medical Holding
SeaStar Medical, the developer of a unique device for selective cytopheretic blood filtration, is extremely sensitive to news. Its weekly stock price is a direct response to data from clinical trials for the treatment of acute kidney injury in children and adults, which will determine the future of the technology.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
SeaStar Medical operates in the volatile biopharmaceutical sector, where investor sentiment often influences all players. M&A news or general regulatory changes can lift or derail the entire sector. The chart will show whether ICU is moving with the industry or whether specific developments are creating their own story.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
SeaStar Medical, as a biotech company, often ignores broader market trends. Its fate depends not on GDP or inflation, but on the results of clinical trials. The chart below clearly demonstrates how ICU shares can rise or fall on its own news, while the overall market moves in a different direction.
Market capitalization of the company, segment and market as a whole
ICU - Market capitalization of the company SeaStar Medical Holding
SeaStar Medical's market cap reflects a focused bet on the treatment of acute kidney injury. The stock price of this company, which is developing a device for selective blood filtration, reflects investor expectations for its technology. Its dynamics reflect the market's speculative assessment of its chances of saving lives and achieving commercial success.
ICU - Share of the company's market capitalization SeaStar Medical Holding within the market segment - Therapeutic medical equipment
SeaStar Medical has developed a selective cytopheretic filtration device that reduces the overactive immune response in critically ill patients. Its market share in the medical device sector is based on this unique technology. The graph shows its potential for treating acute kidney injury and sepsis.
Market capitalization of the market segment - Therapeutic medical equipment
SeaStar Medical develops medical devices for the selective removal of hyperactive neutrophils from the blood, which helps combat cytokine storms. The chart below shows the market capitalization of the therapeutic devices sector. This represents the valuation of this breakthrough technology for the treatment of acute inflammation.
Market capitalization of all companies included in a broad market index - GURU.Markets
SeaStar Medical develops devices for selective cytopheretic filtration to reduce hyperinflammatory processes in acute kidney diseases and other conditions. Its market capitalization is a bet on this technology. The chart below shows the weightings of companies in this field.
Book value capitalization of the company, segment and market as a whole
ICU - Book value capitalization of the company SeaStar Medical Holding
SeaStar Medical's book value represents the capital needed to develop a single device. Its foundation consists of patents for a selective cytopheretic device (SCD) for reducing hyperactive immune responses in critically ill patients and funding for its clinical trials. The chart below shows how the company is using its resources to bring this lifesaving technology to market.
ICU - Share of the company's book capitalization SeaStar Medical Holding within the market segment - Therapeutic medical equipment
SeaStar Medical develops blood purification devices. Its assets include R&D laboratories and pilot production lines. The S_BCap_Seg graph shows its share of the physical infrastructure in the therapeutic medical device sector.
Market segment balance sheet capitalization - Therapeutic medical equipment
SeaStar Medical develops medical devices for selective cytopheretic therapy. It's a knowledge-intensive business, where value is concentrated in patents and clinical data. A book value chart shows that the company, like many in the medtech sector, has a small tangible asset base.
Book value of all companies included in the broad market index - GURU.Markets
SeaStar Medical's assets include blood purification technology. The company's book value reflects its manufacturing capacity for a selective cytopheretic device (SCD) that combats hyperactive inflammation. This material base is aimed at saving patients with acute kidney injury and other critical conditions.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - SeaStar Medical Holding
SeaStar Medical develops devices for selective cytopheretic therapy that purify the blood during severe inflammation. The company's book value is small. Its market capitalization reflects its unique technology and the hopes that it will save the lives of critically ill patients.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
SeaStar Medical develops medical devices for the selective removal of cytokines from the blood during inflammatory processes. The company's value lies in its technology. The chart shows how the market values the life-saving potential of this device compared to its current assets.
Market to book capitalization ratio for the market as a whole
SeaStar Medical develops medical devices for selective cytopheretic therapy to reduce inflammation in critically ill patients. The company's valuation is based on the life-saving potential of its unique technology. The chart shows how the market valuation reflects expectations for approval and adoption of this innovative treatment.
Debts of the company, segment and market as a whole
ICU - Company debts SeaStar Medical Holding
SeaStar Medical, a developer of critical care medical devices, is using debt to finance clinical trials and bring its product to market. This chart shows the capital raised to test its selective cytopheretic filtration technology, designed to treat acute kidney injury.
Market segment debts - Therapeutic medical equipment
SeaStar Medical is a company developing devices for selective cytopheretic therapy aimed at removing cytokines from the blood during acute inflammation. Being in the clinical trials and early commercialization stages, it incurs significant expenses. This chart reflects its financial structure, which depends on its ability to raise capital to continue operations.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio SeaStar Medical Holding
SeaStar Medical is a medical device company developing devices for extracorporeal therapy. This chart shows its reliance on debt. For a company in the commercialization stage of its product, debt may be necessary for building sales and marketing, but it also creates pressure on achieving operating profitability.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
SeaStar Medical develops critical care medical devices. This business requires significant investment in clinical trials and regulatory approvals. This chart for the medical device sector shows how the industry as a whole funds innovation, allowing one to assess risks and company strategy.
Debt to book value of all companies in the market
SeaStar Medical develops medical devices for the selective removal of proinflammatory cytokines from the blood during acute inflammatory reactions. This chart, showing the debt-to-book value ratio of the entire market, is important for assessing the investment climate in biotech. The market's willingness to finance companies with long development cycles determines their future.
P/E of the company, segment and market as a whole
P/E - SeaStar Medical Holding
SeaStar Medical is developing a selective cytopheretic filtration device designed to reduce hyperinflammatory processes in critically ill patients. This graph reflects the hopes for saving lives. Its value demonstrates the level of investor confidence in the technology's ability to help critically ill patients, revealing a large potential market.
P/E of the market segment - Therapeutic medical equipment
SeaStar Medical operates in the therapeutic medical devices sector. This chart shows the average P/E ratio for this innovative industry. A company's P/E is higher than average, indicating that investors have high hopes for its blood filtration technology and its ability to save the lives of critically ill patients.
P/E of the market as a whole
SeaStar Medical is developing a therapeutic device for the selective removal of hyperactive neutrophils and monocytes from the blood, which could help treat acute kidney injury and other inflammatory conditions. This chart illustrates the risk appetite in biotech. It helps understand how the market views the potential of this unique platform for treating critical conditions and the risks it sees in its clinical trials.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company SeaStar Medical Holding
SeaStar Medical is developing a selective cytopheretic therapy device designed to reduce hyperactive inflammation in critically ill patients. The chart shows investor expectations, which hinge on the success of clinical trials and FDA approval for this innovative treatment approach.
%20P%2FE%20SeaStar%20Medical%20Holding&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-SeaStar-Medical-Holding&v=1772513763218 "Chart of the company's future (projected) P/E SeaStar Medical Holding")
Future (projected) P/E of the market segment - Therapeutic medical equipment
SeaStar Medical has developed a selective cytopheretic therapy device that removes hyperactive neutrophils from the blood to treat acute kidney injury. This chart shows how its future revenue expectations compare to the industry average, reflecting its potential for treating critical illnesses.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Therapeutic-medical-equipment&v=1772513763257 "Future (projected) P/E graph of the market segment - Therapeutic medical equipment")
Future (projected) P/E of the market as a whole
SeaStar Medical is a medical company that has developed a device for selective cytopheretic therapy that helps reduce the overactive immune response in sepsis and acute kidney injury. Its success depends on regulatory approval and hospital adoption, not on general economic cycles.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513763284 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit SeaStar Medical Holding
SeaStar Medical is a medical device company developing devices for selective cytopheretic therapy aimed at removing hyperactive immune cells from the blood in critical conditions. Currently in clinical trials, the company incurs significant R&D expenditures. This chart reflects its investment in developing an innovative treatment for life-threatening inflammation.
Profit of companies in the market segment - Therapeutic medical equipment
SeaStar Medical is developing a medical device for the selective removal of hyperactive neutrophils and monocytes from the blood to treat acute kidney injury. This graph shows the profitability of this therapeutic device. The success of this innovative technology could radically change approaches to critical care treatment and create a new, highly profitable market segment.
Overall market profit
SeaStar Medical is a company developing medical devices for selective cytopheretic therapy aimed at reducing hyperinflammation in acute kidney disease. The company's success depends on clinical trial results and FDA approval. This chart shows common economic cycles as SeaStar works to address critical medical needs.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company SeaStar Medical Holding
SeaStar Medical is a company developing a medical device for selective cytopheretic therapy designed to reduce immune system hyperactivity in acute conditions. The revenue projections presented here are dependent on the success of clinical trials and regulatory approval. This demonstrates the market's confidence in the potential of this innovative technology in critical care.
%20profit%20of%20the%20company%20SeaStar%20Medical%20Holding&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-SeaStar-Medical-Holding&v=1772513763601 "Graph of future (projected) profit of the company SeaStar Medical Holding")
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
SeaStar Medical Holding Corp. is a medical technology company developing solutions for selective cytopheretic blood filtration for acute kidney injury. This chart shows profitability forecasts for the therapeutic device sector. It reflects expectations for new treatments for critical conditions in intensive care.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Therapeutic-medical-equipment&v=1772513763667 "Graph of future (predicted) profits of companies in a market segment - Therapeutic medical equipment")
Future (predicted) profit of the market as a whole
SeaStar Medical creates intensive care devices. Demand for their products isn't dependent on economic cycles, but there is potential for growth. The favorable overall profit outlook, reflected in the chart, means hospitals will have more funds to purchase new equipment, and investors will be more willing to fund further development.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513763756 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - SeaStar Medical Holding
SeaStar Medical Holding is a medical company developing devices for selective cytopheretic therapy, which reduces inflammation in critically ill patients. At the commercialization stage, P/S becomes critical, demonstrating investors' confidence in hospitals' adoption of this vital technology.
P/S market segment - Therapeutic medical equipment
SeaStar Medical is a medical device company that has developed a device for selective cytopheretic therapy that reduces the hyperactive inflammatory response in critically ill patients. This chart shows how the market views the potential of their unique technology to save lives in critical conditions and its future revenue streams.
P/S of the market as a whole
SeaStar Medical is a company developing medical devices to reduce immune system hyperactivity in critically ill patients. It has no revenue, and its valuation reflects the technology's potential. This chart, based on actual revenue, clearly demonstrates that SeaStar's valuation is a bet on future success in treating critical illnesses.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company SeaStar Medical Holding
SeaStar Medical is a medical device company developing selective cytopheretic blood filtration devices designed to reduce hyperactive inflammation in acute conditions. This chart reflects investor expectations for future revenue from this targeted therapy, which may have applications in the treatment of acute kidney injury.
%20P%2FS%20SeaStar%20Medical%20Holding&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-SeaStar-Medical-Holding&v=1772513763947 "The graph of the company's future (projected) P/S SeaStar Medical Holding")
Future (projected) P/S of the market segment - Therapeutic medical equipment
SeaStar Medical Holding Corporation is a medical technology company developing solutions to reduce hyperactive inflammation, which causes organ damage. This chart shows how the market perceives the future commercial potential of its therapeutic devices. It compares the company to its competitors, reflecting its belief in its unique approach to treating critical illnesses.
%20P%2FS%20market%20segment%20graph%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Therapeutic-medical-equipment&v=1772513763991 "Future (projected) P/S market segment graph - Therapeutic medical equipment")
Future (projected) P/S of the market as a whole
SeaStar Medical is a company that has developed a device for selectively removing hyperactive neutrophils from the blood, which helps combat the cytokine storm associated with acute inflammation. This chart shows overall market revenue expectations, and the ICU demonstrates how breakthrough technologies in intensive care can save lives and create new markets.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513764026 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales SeaStar Medical Holding
SeaStar Medical is a company specializing in critical care medical devices. This chart shows its revenue generated from sales of the selective cytopheretic device (SCD). This device is designed to reduce immune system overactivity in critically ill patients, such as those with acute kidney injury.
Sales of companies in the market segment - Therapeutic medical equipment
SeaStar Medical is a company developing therapeutic devices to reduce immune system overactivity. Currently, its revenue, if any, may come from government contracts or grants. This chart allows investors to evaluate the funding sources supporting its clinical development.
Overall market sales
SeaStar Medical develops medical devices to reduce inflammation in acute organ diseases. Its target market is intensive care units. Demand for such life-saving technologies is independent of economic cycles, as reflected in this chart. The company's success is determined solely by the clinical effectiveness of its products.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company SeaStar Medical Holding
SeaStar Medical is a company developing medical devices to reduce the inflammatory response in critically ill patients. Its revenue forecast is dependent on the approval and implementation of its technology in intensive care units. This chart reflects analysts' speculative expectations for the commercialization of its innovative products.
%20sales%20of%20the%20company%20SeaStar%20Medical%20Holding&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-SeaStar-Medical-Holding&v=1772513764202 "Schedule of future (projected) sales of the company SeaStar Medical Holding")
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
SeaStar Medical develops therapeutic devices to reduce immune system hyperactivity in critically ill patients. This chart shows projected revenue for the therapeutic medical device sector. It reflects the demand for new treatments in intensive care units, which is key to the commercialization of SeaStar's technology.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Therapeutic-medical-equipment&v=1772513764212 "Schedule of future (projected) sales of companies in the market segment - Therapeutic medical equipment")
Future (projected) sales of the market as a whole
SeaStar Medical is developing a medical device for the selective removal of hyperactive neutrophils from the blood, which may help treat acute kidney injury. The company's success depends on the results of clinical trials. This graph of overall market expectations reflects the investment climate, which is important for funding capital-intensive R&D projects in late-stage medical technology.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513764221 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality SeaStar Medical Holding
SeaStar Medical is a medical device company developing devices for selective cytopheretic therapy aimed at removing hyperactive neutrophils from the blood. This graph reflects the clinical trial stage. The company's future profitability depends entirely on the success and commercialization of this innovative technology.
Market segment marginality - Therapeutic medical equipment
SeaStar Medical is a company developing therapeutic devices to reduce the effects of hyperactive inflammation in critically ill patients. This chart shows the average profit margin in the medical device sector. It helps estimate the potential profitability of selective cytopheretic filtration (SCD) technology in the treatment of critical illnesses.
Market marginality as a whole
SeaStar Medical Holding Corporation develops medical devices to reduce inflammation in critically ill patients. This is a highly specialized area of medicine. This overall profitability chart is irrelevant to the company's valuation, as its prospects depend entirely on clinical trial results and FDA approval.
Employees in the company, segment and market as a whole
Number of employees in the company SeaStar Medical Holding
SeaStar Medical is developing a medical device for selective cytopheretic blood filtration. Its small team is focused on conducting clinical trials and obtaining regulatory approvals. This chart shows the size of the research team working on this innovative treatment.
Share of the company's employees SeaStar Medical Holding within the market segment - Therapeutic medical equipment
SeaStar Medical Holding Corporation is a company developing medical devices to reduce immune system hyperactivity. This chart highlights its focus on critical care. It reflects the proportion of immunologists and biomedical engineers working on a unique technology for treating acute kidney injury in children.
Number of employees in the market segment - Therapeutic medical equipment
SeaStar Medical Holding develops medical devices to reduce immune system overactivity in critical conditions. This chart shows employment in the therapeutic medical device sector. The growing number of specialists in this field reflects the need for new treatments for acute kidney injury and sepsis in intensive care units.
Number of employees in the market as a whole
SeaStar Medical Holding Corporation is a company developing therapeutic devices to reduce immune system overactivity. Development in the medical device sector requires the involvement of engineers and clinicians. This chart shows the overall employment trend, which is influenced by investments in new treatments and technologies.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company SeaStar Medical Holding (ICU)
SeaStar Medical develops therapeutic equipment. Its value lies in its scientific developments and patents. This chart shows the enormous value the market places on each team member working on creating life-saving technology. It's a pure valuation of the company's potential and intellectual property.
%20of%20the%20company%20SeaStar%20Medical%20Holding%20(ICU)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-SeaStar-Medical-Holding-ICU&v=1772513764519 "Chart of market capitalization per employee (in thousands of dollars) of the company SeaStar Medical Holding (ICU)")
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
SeaStar Medical develops medical devices for blood purification in critical conditions. The market capitalization per employee for such a company is an estimate of the life-saving potential of its technology. If the figure is above the sector average, investors highly value the uniqueness of its product and see a large potential market.
%20by%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Therapeutic-medical-equipment&v=1772513764591 "Market capitalization per employee (in thousands of dollars) by market segment - Therapeutic medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
SeaStar Medical is a company developing a selective cytopheretic therapy device designed to reduce inflammation in critically ill patients. This is a breakthrough technology. This chart reflects investor hopes that the small team will successfully complete clinical trials and bring this life-saving device to market.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513764697 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company SeaStar Medical Holding (ICU)
SeaStar Medical (ICU) is developing a selective blood filtration technology to reduce hyperactive inflammation (for example, in kidney failure). This R&D business is in the clinical trials stage. This negative graph shows how much capital is being burned per scientist trying to bring this life-saving technology to market.
%20Chart%20SeaStar%20Medical%20Holding%20(ICU)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-SeaStar-Medical-Holding-ICU&v=1772513764738 "Company Profit Per Employee (in thousands of dollars) Chart SeaStar Medical Holding (ICU)")
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
SeaStar Medical develops medical devices for selective cytopheretic therapy aimed at removing proinflammatory agents from the blood during acute conditions. This graph illustrates the potential of their technology. It demonstrates the high profit potential of an innovative, life-saving device, a key indicator of value in the biotech sector.
%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Therapeutic-medical-equipment&v=1772513764756 "Chart of profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
SeaStar Medical Holding (ICU) is a company developing medical devices for selective cytopheretic therapy (treatment of acute kidney injury). This is a high-tech R&D company. The chart shows the investment (expenses) per employee during clinical trials and regulatory approvals. The goal is high profit per employee after commercialization.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513764794 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee SeaStar Medical Holding (ICU)
SeaStar Medical, a company developing blood purification devices for acute kidney injury, is in the clinical trials and early commercialization phase. This graph shows the company's early development. Growth in revenue per employee will be a key indicator of the adoption of its technology by hospitals and physicians.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-SeaStar-Medical-Holding-ICU&v=1772513764797 "Sales chart per company employee SeaStar Medical Holding (ICU)")
Sales per employee in the market segment - Therapeutic medical equipment
SeaStar Medical Holding (ICU) is a medical device company specializing in extracorporeal therapy (blood purification) devices for the treatment of acute kidney injury. This chart shows the average revenue per employee in the segment. Comparing ICU to this benchmark demonstrates how effectively the company is commercializing its life-saving devices for intensive care units.
Sales per employee for the market as a whole
SeaStar Medical (ICU) is a medical technology company in the commercialization stage that has developed a blood purification device for sepsis patients. Like HSDT, this figure currently reflects the initial steps toward bringing the product to market. Investors are monitoring its growth, which will indicate that hospitals are actively adopting their technology.
Short shares by company, segment and market as a whole
Shares shorted by company SeaStar Medical Holding (ICU)
SeaStar Medical (ICU) is a medical company developing selective blood filtration devices (hemofiltration) for the treatment of acute kidney injury. This chart shows the odds on the failure of their technology. "Bears" believe the company will be unable to prove in clinical trials that its expensive device truly saves lives.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-SeaStar-Medical-Holding-ICU&v=1772513764881 "Short Shares Chart for the Company SeaStar Medical Holding (ICU)")
Shares shorted by market segment - Therapeutic medical equipment
SeaStar Medical (ICU) develops blood purification devices for acute inflammation, such as kidney failure in the intensive care unit. This chart highlights the pessimism in the sector. The surge in short positions across the industry is a bet that hospitals will not implement new, expensive treatments in intensive care units. Investors doubt the clinical data or whether insurers will cover these therapies.
Shares shorted by the overall market
SeaStar Medical develops devices to purify blood from inflammatory cytokines, targeting patients in the intensive care unit. This chart measures the overall fear. When investors are pessimistic, they are extremely wary of early-stage medtech. They fear that ICU will fail to prove the effectiveness of its therapy or obtain FDA approval, and they prefer to exit the risky asset.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator SeaStar Medical Holding (ICU)
SeaStar Medical (ICU) develops medical devices for selective blood filtration for the treatment of acute kidney injury and inflammatory conditions. This is a critical area of medicine. This oscillator measures the rate of price change. It helps identify when investor enthusiasm (above 70) or disappointment (below 30) about clinical data peaks.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-SeaStar-Medical-Holding-ICU&v=1772513764976 "RSI 14 indicator chart for the company's stock SeaStar Medical Holding (ICU)")
RSI 14 Market Segment - Therapeutic medical equipment
SeaStar Medical (ICU) has developed a device (Quelimmune) that "filters" blood in the intensive care unit, removing hyperactive neutrophils to stop the cytokine storm that occurs in sepsis. This graph tracks the pulse of the Therapeutic Equipment sector. It helps differentiate ICU technology from the overall "overheated" or "oversold" medtech sector.
RSI 14 for the overall market
SeaStar Medical (ICU) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria is an opportunity to easily raise hundreds of millions of dollars for research. Market panic is the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ICU (SeaStar Medical Holding)
SeaStar Medical is a medical technology company that developed the Selective Cytopheretic Device (SCD). It's a blood filter used in the medical field to remove overactive immune cells (called cytokine storms). This chart shows the speculative average price target from analysts, based on their belief in the approval and adoption of this therapy.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ICU-SeaStar-Medical-Holding&v=1772513765038 "A chart showing analyst consensus forecasts for the expected stock price. ICU (SeaStar Medical Holding)")
The difference between the consensus estimate and the actual stock price ICU (SeaStar Medical Holding)
SeaStar Medical is a medical technology company that has developed a unique blood filter (Selective Cytopheretic Device) for the treatment of acute inflammation in intensive care patients. This chart measures the gap between the current price and the consensus target price. It shows how much confidence experts have in this R&D platform.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ICU-SeaStar-Medical-Holding&v=1772513765095 "A chart showing the difference between the consensus forecast and the actual stock price. ICU (SeaStar Medical Holding)")
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
SeaStar Medical (ICU) is a medical company that has developed a device for "filtering" blood in the intensive care unit. It eliminates the "cytokine storm" in patients with organ failure. This chart shows general expectations for the therapeutic medical equipment sector. It reflects whether experts believe in this innovative intensive care method.
Analysts' consensus forecast for the overall market share price
SeaStar Medical is a medical company that has developed a device (Selective Cytopheretic Device) for filtering blood in critically ill patients (sepsis, kidney failure). This chart shows the overall "risk appetite" in the market. For SeaStar, a company with a breakthrough but risky technology, overall market optimism is important for attracting capital for clinical trials.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index SeaStar Medical Holding
SeaStar Medical is a last-resort MedTech company. Their signature product is a selective filter (cartridge) that attaches to a dialysis machine and removes overactive immune cells from the blood to stop cytokine storms (sepsis). This graph is a clear indicator of their R&D efforts. It reflects their (very risky) path to FDA approval for this life-saving therapy.
AKIMA Market Segment Index - Therapeutic medical equipment
SeaStar Medical (ICU) is a medical technology company that developed the Selective Cytopheretic Device (SCD). This device calms the overactive immune system in critically ill patients (such as those with sepsis). The chart shows the average index for the segment, helping investors assess how this vital technology compares to the average market.
The AKIM Index for the overall market
SeaStar Medical (ICU) is a MedTech company developing a device (SCD) for the treatment of acute inflammation and cytokine storm. This chart, which reflects the market average, provides context. It helps assess how this innovative intensive care technology compares to overall macroeconomic trends and regulatory decisions.
